Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
935.20 DKK | +1.34% | +2.03% | +21.17% |
08-26 | COLOPLAST : Q3 24: Chronic care momentum makes up for urology pain | |
08-21 | Jyske Bank Downgrades Coloplast to Hold, Trims PT | MT |
Fiscal Period: September | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Income | 3.87B | 4.2B | 4.82B | 4.71B | 4.78B | |||||
Depreciation & Amortization - CF | 500M | 692M | 663M | 670M | 735M | |||||
Amortization of Goodwill and Intangible Assets - (CF) | 118M | 118M | 82M | 190M | 245M | |||||
Depreciation & Amortization, Total | 618M | 810M | 745M | 860M | 980M | |||||
Amortization of Deferred Charges, Total - (CF) | 33M | 41M | 47M | 70M | 89M | |||||
(Gain) Loss From Sale Of Asset | -24M | 2M | 4M | 7M | 3M | |||||
Other Operating Activities, Total | 148M | 61M | -256M | 305M | -736M | |||||
Change In Accounts Receivable | -222M | 81M | -235M | -351M | -392M | |||||
Change In Inventories | -197M | -403M | -161M | -540M | -474M | |||||
Change In Accounts Payable | 145M | 120M | 224M | 337M | -38M | |||||
Change in Other Net Operating Assets | -17M | -150M | 97M | -295M | 11M | |||||
Cash from Operations | 4.36B | 4.76B | 5.29B | 5.1B | 4.23B | |||||
Capital Expenditure | -617M | -846M | -919M | -927M | -1.02B | |||||
Sale of Property, Plant, and Equipment | 47M | 5M | 36M | 11M | 8M | |||||
Cash Acquisitions | - | - | -97M | -10.63B | -7.92B | |||||
Divestitures | - | - | - | - | - | |||||
Sale (Purchase) of Intangible assets | -73M | -85M | -1.05B | -208M | -221M | |||||
Investment in Marketable and Equity Securities, Total | -2M | 25M | 16M | -2M | 199M | |||||
Other Investing Activities, Total | 54M | - | - | - | - | |||||
Cash from Investing | -591M | -901M | -2.01B | -11.76B | -8.96B | |||||
Short Term Debt Issued, Total | - | 45M | 1.05B | - | 622M | |||||
Long-Term Debt Issued, Total | - | - | - | 16.37B | - | |||||
Total Debt Issued | - | 45M | 1.05B | 16.37B | 622M | |||||
Short Term Debt Repaid, Total | -196M | - | - | -5.4B | - | |||||
Long-Term Debt Repaid, Total | - | -197M | -202M | -239M | -244M | |||||
Total Debt Repaid | -196M | -197M | -202M | -5.64B | -244M | |||||
Issuance of Common Stock | 380M | 407M | 306M | - | 9.13B | |||||
Repurchase of Common Stock | -500M | -500M | -500M | -500M | - | |||||
Common Dividends Paid | -2.34B | -3.61B | -3.83B | -4.04B | -4.25B | |||||
Common & Preferred Stock Dividends Paid | -2.34B | -3.61B | -3.83B | -4.04B | -4.25B | |||||
Special Dividend Paid | -1.06B | - | - | - | - | |||||
Other Financing Activities, Total | - | - | - | 402M | - | |||||
Cash from Financing | -3.71B | -3.86B | -3.18B | 6.59B | 5.26B | |||||
Foreign Exchange Rate Adjustments | - | - | - | - | - | |||||
Miscellaneous Cash Flow Adjustments | 7M | -34M | 22M | 35M | -37M | |||||
Net Change in Cash | 59M | -33M | 125M | -34M | 497M | |||||
Supplemental Items | ||||||||||
Cash Interest Paid | 207M | 191M | 81M | 378M | 809M | |||||
Cash Income Tax Paid (Refund) | 1.18B | 1.28B | 1.5B | 1.12B | 1.73B | |||||
Levered Free Cash Flow | 3.21B | 3.18B | 2.72B | 3.75B | 6.36B | |||||
Unlevered Free Cash Flow | 3.22B | 3.2B | 2.74B | 3.86B | 6.76B | |||||
Change In Net Working Capital | 277M | 420M | 101M | 313M | -2.6B | |||||
Net Debt Issued / Repaid | -196M | -152M | 848M | 10.73B | 378M |